AI assistant
Sending…
Bolt Biotherapeutics, Inc. — Director's Dealing 2021
Feb 9, 2021
35210_dirs_2021-02-09_5d66ba69-b98f-45cb-ba9c-b7168026a8ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Bolt Biotherapeutics, Inc. (BOLT)
CIK: 0001641281
Period of Report: 2021-02-09
Reporting Person: LAPORTE KATHLEEN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-09 | Common Stock | P | 1200 | $20.00 | Acquired | 1200 | Direct |
More from Bolt Biotherapeutics, Inc.
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2025
Dec 16
Director's Dealing
2025
Dec 16
Director's Dealing
2025
Dec 16
Director's Dealing
2025
Dec 16